CDDO-Me also inhibited expression of chemokines that mediate selective recruitment of TAMs and M2 macrophages, (CCL3, CCL4, and eotaxin) [39–41] and monocytic infiltration of tumor sites (CCL2 and CCL5) [42] (Fig 4D). The gene discussed is CCL5; the disease is neoplasm.